03 February 2019 | EventsNCIRS Seminar/Webinar for providers: Monday 18 Feb 2019 – Conversations with vaccine-hesitant parents: how the new SKAI website can helpRead the full article
Post-licensure surveillance of adverse events following immunisation (AEFI) is an important component of any national immunisation program and essential to maintaining the confidence of the general public and immunisation providers in the national immunisation program.
NCIRS plays a pivotal and collaborative role in monitoring and promoting vaccine safety. The Therapeutic Goods Administration (TGA), which conducts monitoring of AEFI through national passive surveillance, sends AEFI reports related to vaccines in a de-identified form to NCIRS to conduct various analyses. We analyse these data to prepare regular national AEFI surveillance reports, national immunisation program evaluations, reports to the Australian Technical Advisory Group on Immunisation (ATAGI) and other ad hoc analyses. Find out more here.
NCIRS also collaborates with other organisations on a range of important vaccine safety activities:
Paediatric Active Enhanced Disease Surveillance (PAEDS)
NSW Immunisation Specialist Service (NSWISS)
NCIRS's vaccine safety fact sheets provide information on specific issues. These fact sheets have been developed primarily for immunisation providers, but may also be of interest to members of the public.
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.